Insight

Aug 10, 2024, 13:45

Katsuaki Maehara: EGFR mutated NSCLC

Katsuaki Maehara, Director of Medical Education Colleagues shared a post on X:

“EGFR mutated NSCLC.

This article is the latest data to analyze the concomitant driver alteration of EGFR mutated NSCLC using NGS.

It is also an important dictionary for selecting effective treatment regimens from the analysis results and for encouraging the development of combination therapies.

For all patients with EGFR mutation-positive disease.”

Source: Katsuaki Maehara/X

Landscape of Concomitant Driver Alterations in Classical EGFR-Mutated Non–Small Cell Lung Cancer.

Authors: Huaying Wang, Lie Lin, Chuqiao Liang, Jiaohui Pang, Jiani C. Yin, Junli Zhang, Yang Shao, Chengming Sun, and Renhua Guo.

Katsuaki Maehara

cancer Chengming Sun Chuqiao Liang EGFR Huaying Wang Jiani C. Yin Jiaohui Pang Junli Zhang Katsuaki Maehara Lie Lin non small cell lung cancer NSCLC OncoDaily Oncology Renhua Guo Yang Shao

Padraic O’Malley: Meet the Experts of VIRO 2025

Hidden Risks: BRCA Mutations and Breast Implants - CancerWorld

FDA Breakthrough Therapy Designation for Iza-bren: Advancing Treatment for EGFR-Mutant NSCLC

Neil Ranasinghe: What’s the Difference Between a Clinician and a Technical Author?

LOCKTAC Molecular Glues Are Changing the Rules of Drug Discovery - Amgen